Nanoarrays vs Microarrays
Microarrays have become indispensable for high-throughput analysis. However, microarrays are now being superseded by nanoarrays, which have a higher sensitivity […]
» Read moreFlow cytometry can be used to analyze different cell types. This technique can be applied to immunology to ensure that, […] Over two million babies, children, and adults in the United States are living with congenital heart disease—a range of birth […] Epigenetic mechanisms present alternative targeting opportunities, but their contributions to Ewing sarcoma metastasis and disease progression remain poorly understood. Here, […] A study conducted by researchers at São Paulo State University (UNESP) suggests that irisin, a hormone secreted from muscles in […] Scientists have unveiled clues into why some cancer patients develop a serious heart condition after chemotherapy. The new research, from […] Antibiotic resistance does not spread only where and when antibiotics are used in large quantities, researchers conclude from laboratory experiments. […] The discovery that an essential protein plays a protective role during cell division, could open the door to better targeted […] Building on a track record of developing adeno-associated viral (AAV) vectors as a groundbreaking clinical tool for gene therapy and […] A newly described form of stress called chromatin architectural defect, or chromatin stress, triggers in cells a response that leads […]
Flow Cytometry Cross-matching (FCXM)
Study reveals networks of genes involved in congenital heart disease
KDM5A and PHF2 positively control expression of pro-metastatic genes
Exercise hormone may modulate genes associated with replication of novel coronavirus
Heart damage from cancer drugs linked to faulty genes
Resistance can spread even without the use of antibiotics
Protective protein guards against DNA damage and could help target fast growing cancer cells
Research team redefines the footprint of viral vector gene therapy
A moderate dose of novel form of stress promotes longevity
